Biomimetic nanoplatform with H2O2 homeostasis disruption and oxidative stress amplification for enhanced chemodynamic therapy
Source abstract
Abstract
Chemodynamic therapy (CDT) is a powerful cancer treatment strategy by producing excessive amount of reactive oxygen species (ROS) to kill cancer cells. However, the inadequate hydrogen peroxide (H2O2) supply and antioxidant defense systems in tumor tissue significantly impair the therapeutic effect of CDT, hindering its further applications. Herein, we present an intelligent nanoplatform with H2O2 homeostasis disruption and oxidative stress amplification properties for enhanced CDT. This nanoplatform is obtained by encapsulating glucose oxidase (GOx) in a pH- and glutathione (GSH)-responsive degradable copper doped-zeolitic imidazolate framework (Cu-ZIF8), followed by loading of 3-amino-1,2,4-triazole (3AT) and modification of hyaluronic acid (HA) for tumor targeting delivery. The GOx@Cu-ZIF8-3AT@HA not only reduces energy supply and increases H2O2 level by exhausting intratumoral glucose, but also disturbs tumor antioxidant defense systems by inhibiting the activity of catalase (CAT) and depleting intracellular GSH, resulting in disrupted H2O2 homeostasis in tumor. Moreover, the elevated H2O2 will transform into highly toxic hydroxyl radical (·OH) by Cu+ that generated from redox reaction between Cu2+ and GSH, amplifying the oxidative stress to enhance the CDT efficacy. Consequently, GOx@Cu-ZIF8-3AT@HA has significantly inhibited the 4T1 xenograft tumor growth without discernible side effects, which provides a promising strategy for cancer management. STATEMENT OF SIGNIFICANCE: The inadequate H2O2 level and antioxidant defense system in tumor tissues significantly impair the therapeutic effect of CDT. Herein, we developed an intelligent nanoplatform with H2O2 homeostasis disruption and oxidative stress amplification properties for enhanced CDT. In this nanoplatform, GOx could exhaust intratumoral glucose to reduce energy supply accompanied with production of H2O2, while the suppression of CAT activity by 3AT and depletion of GSH by Cu2+ would weaken the antioxidant defense system of tumors. Ultimately, the raised H2O2 level would convert to highly toxic •OH by Fenton-like reaction, amplifying the CDT efficacy. This work provides a promising strategy for cancer management.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (56)
Show source-provided references
1. Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles10.1016/j.redox.2016.12.011 ↗
2. Oxidative stress and cancer: an overview10.1016/j.arr.2012.10.004 ↗
3. Stimuli-responsive therapeutic metallodrugs10.1021/acs.chemrev.8b00209 ↗
4. The double-edged roles of ROS in cancer prevention and therapy10.7150/thno.56747 ↗
5. Type I photodynamic therapy by organic-inorganic hybrid materials: from strategies to applications10.1016/j.ccr.2019.05.016 ↗
6. Oxidative stress10.1146/annurev-biochem-061516-045037 ↗
7. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?10.1038/nrd2803 ↗
8. Emerging nanomedicine-enabled/enhanced nanodynamic therapies beyond traditional photodynamics10.1002/adma.202005062 ↗
9. Synthetic biology-instructed transdermal microneedle patch for traceable photodynamic therapy10.1038/s41467-022-33837-1 ↗
10. Nanotechnology for multimodal synergistic cancer therapy10.1021/acs.chemrev.7b00258 ↗
11. Tumor-specific activatable nanocarriers with gas-generation and signal amplification capabilities for tumor theranostics10.1021/acsnano.0c09223 ↗
12. Biodegradable calcium phosphate nanotheranostics with tumor-specific activatable cascade catalytic reactions-augmented photodynamic therapy10.1002/adfm.202009848 ↗
13. Protective effect of Co-enzyme Q10 on doxorubicin-induced cardiomyopathy of rat hearts10.1002/tox.22270 ↗
14. Mechanisms of cisplatin-induced ototoxicity and otoprotection10.3389/fncel.2017.00338 ↗
15. Application of glutathione depletion in cancer therapy: enhanced ROS-based therapy, ferroptosis, and chemotherapy10.1016/j.biomaterials.2021.121110 ↗
16. Mechanisms of multidrug resistance in cancer chemotherapy10.3390/ijms21093233 ↗
17. Reactive oxygen species in tumor metastasis10.1016/j.canlet.2008.02.031 ↗
18. Overcoming the obstacles of current photodynamic therapy in tumors using nanoparticles
19. Conquering the hypoxia limitation for photodynamic therapy10.1002/adma.202103978 ↗
20. Recent advances in nanomaterial-assisted combinational sonodynamic cancer therapy10.1002/adma.202003214 ↗
21. Sonodynamic therapy: Rapid progress and new opportunities for non-invasive tumor cell killing with sound10.1016/j.canlet.2022.215592 ↗
22. Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: a review10.1016/j.actbio.2019.09.009 ↗
23. Overcoming the Achilles' heel of photodynamic therapy10.1039/C6CS00616G ↗
24. Synthesis of iron nanometallic glasses and their application in cancer therapy by a localized Fenton reaction10.1002/anie.201510031 ↗
25. Nanocatalyst-mediated chemodynamic tumor therapy
26. Recent advances on endogenous/exogenous stimuli-triggered nanoplatforms for enhanced chemodynamic therapy10.1016/j.ccr.2021.214267 ↗
27. Sustained release of nitric oxide and cascade generation of reactive nitrogen/oxygen species via an injectable hydrogel for tumor synergistic therapy
28. Nanocatalysts-augmented Fenton chemical reaction for nanocatalytic tumor therapy10.1016/j.biomaterials.2019.04.023 ↗
29. Strategies for enhancing cancer chemodynamic therapy performance10.1002/EXP.20210238 ↗
30. Amorphous Fe-based nanoagents for self-enhanced chemodynamic therapy by Re-establishing tumor acidosis
31. Metabolic responses to reductive stress10.1089/ars.2019.7803 ↗
32. Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels
33. Catalytic chemistry of glucose oxidase in cancer diagnosis and treatment10.1039/C7CS00891K ↗
34. Glucose oxidase-instructed multimodal synergistic cancer therapy10.1002/adma.201808325 ↗
35. Biocatalytic depletion of tumorigenic energy sources driven by cascade reactions for efficient antitumor therapy10.1002/anie.202204584 ↗
36. In vivo three-dimensional multispectral photoacoustic imaging of dual enzyme-driven cyclic cascade reaction for tumor catalytic therapy10.1038/s41467-022-29082-1 ↗
37. In situ sprayed starvation/chemodynamic therapeutic gel for post-surgical treatment of IDH1 (R132H) glioma
38. When starvation therapy meets chemodynamic therapy10.1016/j.chphma.2022.05.001 ↗
39. Biodegradable manganese-doped calcium phosphate nanotheranostics for traceable cascade reaction-enhanced anti-tumor therapy10.1021/acsnano.9b05836 ↗
40. Tumor microenvironment responsive polypeptide-based supramolecular nanoprodrugs for combination therapy10.1016/j.actbio.2022.04.027 ↗
41. Biodegradable metal-organic-framework-gated organosilica for tumor-microenvironment-unlocked glutathione-depletion-enhanced synergistic therapy
42. Tumor metabolism destruction via metformin-based glycolysis inhibition and glucose oxidase-mediated glucose deprivation for enhanced cancer therapy10.1016/j.actbio.2022.04.022 ↗
43. Biomineralized metal-organic framework nanoparticles enable a primer exchange reaction-based DNA machine to work in living cells for imaging and gene therapy10.1039/D0SC00339E ↗
44. Bioinspired construction of a nanozyme-based H2O2 homeostasis disruptor for intensive chemodynamic therapy10.1021/jacs.9b12873 ↗
45. Nanocatalytic theranostics with glutathione depletion and enhanced reactive oxygen species generation for efficient cancer therapy10.1002/adma.202006892 ↗
46. Self-assembled copper-amino acid nanoparticles for in situ glutathione "AND" H2O2 sequentially triggered chemodynamic therapy10.1021/jacs.8b08714 ↗
47. A versatile calcium phosphate nanogenerator for tumor microenvironment-activated cancer synergistic therapy
48. MnO2 motor: a prospective cancer-starving therapy promoter10.1021/acsami.8b01818 ↗
49. Biomineralized metal-organic framework nanoparticles enable intracellular delivery and endo-lysosomal release of native active proteins10.1021/jacs.8b04457 ↗
50. Artificial super neutrophils for inflammation targeting and HClO generation against tumors and infections
51. Selective thrombosis of tumor for enhanced hypoxia-activated prodrug therapy10.1002/adma.202104504 ↗
52. Biodegradable biomimic copper/manganese silicate nanospheres for chemodynamic/photodynamic synergistic therapy with simultaneous glutathione depletion and hypoxia relief10.1021/acsnano.8b09387 ↗
53. Biodegradable nanocatalyst with self-supplying fenton-like ions and H2O2 for catalytic cascade-amplified tumor therapy10.1021/acsami.1c14598 ↗
54. Glucose oxidase-amplified CO generation for synergistic anticancer therapy via manganese carbonyl-caged MOFs10.1016/j.actbio.2022.10.018 ↗
55. Anti-VEGFR2-labeled enzyme-immobilized metal-organic frameworks for tumor vasculature targeted catalytic therapy10.1016/j.actbio.2022.01.037 ↗
56. Janus γ-Fe2O3/SiO2-based nanotheranostics for dual-modal imaging and enhanced synergistic cancer starvation/chemodynamic therapy10.1016/j.scib.2019.12.024 ↗